Australia's most trusted
source of pharma news
Wednesday, 17 June 2026
Posted 17 June 2026 AM
German giant BioNTech has installed two BioNTrainer units at its mRNA facility in Victoria, marking a major milestone as the site nears becoming a clinical-scale manufacturing facility.
Located at La Trobe University’s Bundoora campus, BioNTech’s research and development mRNA laboratory, officially opened in November last year and is expected to transition into the new clinical-scale manufacturing facility once construction has completed later this year.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.